Targeting the C481S Ibrutinib-Resistance Mutation in Bruton's Tyrosine Kinase Using PROTAC-Mediated Degradation.
暂无分享，去创建一个
J. Byrd | A. Johnson | C. Crews | S. Jaime-Figueroa | M. Toure | A. Buhimschi | A. Lehman | J. Woyach | Timothy L. Chen | Haley Armstrong